Dr. Steven Raw FRSC CChem

Dr. Steven Raw FRSC CChem, Team Manager, AstraZeneca Pharmaceutical Technology and Development

Presentation Title: TBC

Abstract: TBC

Bio:  After studying chemistry at UMIST, Steven went on to complete my PhD studies in natural product synthesis and a postdoctoral research fellowship developing telescoped organic processes at the University of York with Prof Richard Taylor.  He joined AstraZeneca as a process chemist in 2004 and became a team manager in 2010.  He has led chemical development teams delivering projects at all stages of the portfolio, from pre-clinical to launch.  A recent success has been the chemical development and launch of osimertinib (Tagrisso®), one of the fastest pharmaceutical development programmes achieved.  He currently works on projects across the AZ portfolio, including exciting new modalities such as antibody-drug conjugates and oligonucleotides, as well as traditional small-molecule therapies.

Steven is also part of the steering group that directs AstraZeneca’s accredited programme with the RSC.  In addition to providing pathways to chartership for our established chemical scientists, this scheme also provides opportunities for accelerated transition to full membership and attainment of the registered scientist designation to our early-career scientists.